Table 1.
Effect of CCM treatment on the distribution of DPOAE amplitudes for 1–8-kHz frequencies in the ear of GEN or NaS administered rats
| Frequencies | Control | OO | CCM | GEN | NaS | CCM+GEN | CCM+NaS |
|---|---|---|---|---|---|---|---|
| 1 kHz | 15.03 ± 0.57 | 15.95 ± 0.97 | 17.50 ± 1.51 | 10.72* ± 1.33 | 12.33* ± 0.26 | 13.05 ± 0.27 | 13.93 ± 0.93 |
| 2 kHz | 16.37 ± 0.58 | 16.85 ± 0.70 | 17.17 ± 1.06 | 10.72* ± 0.65 | 12.60* ± 0.17 | 13.43*# ± 0.26 | 13.55* ± 0.41 |
| 3 kHz | 14.65 ± 0.66 | 13.95 ± 0.22 | 15.83 ± 1.10 | 11.72* ± 0.48 | 12.77* ± 0.11 | 14.23# ± 0.32 | 14.10 ± 0.35 |
| 4 kHz | 14.72 ± 0.88 | 14.53 ± 0.29 | 15.50 ± 0.81 | 11.82* ± 0.55 | 12.42* ± 0.27 | 14.83# ± 0.54 | 15.33# ± 0.81 |
| 5 kHz | 16.92 ± 0.64 | 16.85 ± 0.65 | 18.33 ± 0.36 | 11.53* ± 0.47 | 12.33* ± 0.37 | 13.87*# ± 0.76 | 14.20*# ± 0.65 |
| 6 kHz | 15.53 ± 0.40 | 15.47 ± 1.71 | 16.83 ± 1.12 | 11.10* ± 0.31 | 12.12* ± 0.48 | 14.32# ± 0.61 | 14.82# ± 0.59 |
| 7 kHz | 17.82 ± 1.01 | 16.57 ± 2.38 | 17.83 ± 0.70 | 10.58* ± 0.52 | 11.62* ± 0.21 | 15.35# ± 0.54 | 16.07# ± 1.30 |
| 8 kHz | 17.77 ± 0.63 | 18.42 ± 1.99 | 20.00 ± 1.35 | 11.33* ± 0.42 | 12.23* ± 0.33 | 16.67# ± 0.64 | 18.93# ± 1.10 |
Values are represented as the mean ± SE. n = 10 replicates/treatment
OO olive oil
*Significantly different compared to the control group (i.e., CCM, GEN, NaS, GEN+CCM, or CCM+NaS vs. control group) at P < 0.05
#Significantly different from the respective drug only treated group (i.e., CCM+GEN vs. GEN and CCM+NaS vs. NaS) compared to the control group at P < 0.05